| P50 | author | Scott Coley | Q81481061 |
| P2093 | author name string | Shan Lu | |
| | Shixia Wang | |
| | Song Huang | |
| | Jiaming Li | |
| | Qingyu Zhu | |
| | Innocent Mboudjeka | |
| | Baoan Yang | |
| | John M Lawrence | |
| | Pavlo V Sakhatskyy | |
| | Te-hui W Chou | |
| P2860 | cites work | The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex | Q27477706 |
| | Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus | Q28188496 |
| | A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2 | Q28191005 |
| | Characterization of a novel coronavirus associated with severe acute respiratory syndrome | Q28202401 |
| | A novel coronavirus associated with severe acute respiratory syndrome | Q29617553 |
| | A complete sequence and comparative analysis of a SARS-associated virus (Isolate BJ01) | Q90668345 |
| | The Genome sequence of the SARS-associated coronavirus | Q29619007 |
| | Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein. | Q30336102 |
| | Mass spectrometric characterization of proteins from the SARS virus: a preliminary report | Q30939828 |
| | Proteomic analysis on structural proteins of Severe Acute Respiratory Syndrome coronavirus | Q33197427 |
| | The spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells | Q33207348 |
| | An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies | Q34437463 |
| | Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association | Q36602721 |
| | Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry | Q37356916 |
| | Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production | Q37596633 |
| | Immunization against feline coronaviruses | Q39179645 |
| | The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus. | Q39601306 |
| | Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay. | Q40191379 |
| | Enzyme-linked immunosorbent assay for detection of antibody in volunteers experimentally infected with human coronavirus strain 229 E | Q40231076 |
| | Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system. | Q40471278 |
| | Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein. | Q40599319 |
| | Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein | Q41040181 |
| | A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague | Q41461629 |
| | Cleavage and serum reactivity of the severe acute respiratory syndrome coronavirus spike protein | Q42044449 |
| | The time course of the immune response to experimental coronavirus infection of man. | Q42093984 |
| | Quaternary structure of coronavirus spikes in complex with carcinoembryonic antigen-related cell adhesion molecule cellular receptors | Q43818969 |
| | Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus | Q43877119 |
| | Analysis of multimerization of the SARS coronavirus nucleocapsid protein | Q43965913 |
| | A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice. | Q44110039 |
| | Immunogenicity of SARS inactivated vaccine in BALB/c mice | Q44709506 |
| | Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice | Q44961556 |
| | Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. | Q45046366 |
| | Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry | Q45141976 |
| | Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors | Q45659807 |
| | Ribonucleoprotein of Avian Infectious Bronchitis Virus | Q45801527 |
| | Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus | Q47245952 |
| | Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets | Q47283945 |
| | Identification of two antigenic epitopes on SARS-CoV spike protein | Q47378590 |
| | A highly unusual palindromic transmembrane helical hairpin formed by SARS coronavirus E protein | Q47947874 |
| | An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus | Q47957009 |
| | Medicine. Caution urged on SARS vaccines | Q48019790 |
| | [The application of indirect immuno-fluorescence assay in the diagnosis of severe acute respiratory syndrome] | Q73631335 |
| | Rapid and efficient preparation of monoclonal antibodies against SARS-associated coronavirus nucleocapsid protein by immunizing mice | Q73677114 |
| | [Expression of the monoclonal antibody against nucleocapsid antigen of SARS-associated coronavirus in autopsy tissues from SARS patients] | Q79304807 |
| P433 | issue | 1 | |
| P921 | main subject | Coronaviridae | Q1134583 |
| | SARS-CoV-1 | Q85438966 |
| P304 | page(s) | 134-143 | |
| P577 | publication date | 2005-03-01 | |
| P1476 | title | Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) | |
| P478 | volume | 334 | |